期刊文献+

端粒酶在食管癌组织中表达的观察

The Expression of Telomerase in Esophageal Cancer
暂未订购
导出
摘要 目的 :探讨端粒酶在食管癌组织中表达的情况。方法 :采用免疫组织化学染色的方法检测端粒酶在食管癌组织中的表达。结果 :端粒酶在食管癌组织中表达的阳性率为 6 6 .0 7%( 37/ 5 6 ) ,端粒酶的表达与食管癌淋巴结有无转移的相关性不明显 (P >0 .0 5 ) ,而与食管癌的分化程度有明显的相关性 (P <0 .0 5 )。结论 Objective: To study the significance of the expression of telomerase in esophageal cancer. Methods: Immunohistochemistry is used to detect the expression of telomerase in esophageal cancer. Results: The positive rate of telomerase in esophageal cancer was 66.07%(37/56). The expression of the telomerase has no evident relevance to esophageal cancer lymph node, whether it has transfer or not; but it has evident relevance to esophageal cancer differentiation degree. Conclusion: The positive expression of telomerase were found in the expression of telomerase in esophageal cancer.
出处 《张家口医学院学报》 2004年第3期28-29,共2页
关键词 端粒酶 食管癌 肿瘤 免疫组化 telomerase esophageal cancer immunohistochemistry
  • 相关文献

参考文献7

二级参考文献14

  • 1[1]Lam KY, Lo CY, Fan ST, et al. Telomerase activity in pancreatic endocrine tumours: a potential marker for malignancy[J]. Mol Pathol, 2000,53(3): 133-136.
  • 2[2]Wu A, Ichihashi M, Ueda M. Correlation of the expression of human telomerase subunits with telomerase activity in normal skin and skin tumors[J]. Cancer, 1999,86(10): 2038-2044.
  • 3[3]Kim NW, Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP)[J]. Nucleic Acid Res, 1997,25(6): 2595-2602.
  • 4[4]Ramirez RD, D Atri S, Pagani E, et al. Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma[J]. Neoplasia, 1999,1(1): 42-49.
  • 5[5]Lichtsteiner SP, Lebkowski JS, Vasserot AP. Telomerase. A target for anticancer therapy[J]. Ann N Y Acad Sci, 1999,886(1): 1-11.
  • 6[6]Rha SY, Izbicka E, Lawrence R, et al. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines[J]. Clin Cancer Res, 2000,6(3): 987-993.
  • 7[7]Daniel EG, Tejera AM, Olive OA. Irreversible telomere shortening by 3′-azido-2′,3′-dideoxythymidine (AZT) treatment[J]. Biochem Biophy Res Commun, 1998,246(1): 107-110.
  • 8[8]Zhu XL, Kumar R, Mandal M, et al. Cell cycle-dependent modulation of telomerase activity in tumor cells[J]. Proc Natl Acad Sci USA, 1996,93(7): 6091-6095.
  • 9吴翔,杨光彩.人端粒酶与肿瘤的关系及测定方法[J].国外医学(分子生物学分册),1998,20(2):55-59. 被引量:7
  • 10屈艺,欧阳雪松,刘菽秋,彭晓东,刘柏林.核酶抑制端粒酶活性的实验研究[J].中华医学遗传学杂志,1999,16(3):133-137. 被引量:21

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部